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Biomonitoring and Health 
Disparities – Overview 
For some high disparity diseases, 
particularly cancer and diabetes, 
biomonitoring advances can be 
very significant.  However 
biomonitoring by itself is not 
enough to make the difference.
Disparities in Health in America: 
Working Toward Social Justice
June 24-30, 2006
M D Anderson Cancer Center
Social Justice – involves
Understanding
Changing minds and hearts
Commitments, priorities & action
Equity = an issue, like slavery and 
women’s rights, where society is 
changing its mind
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Biomonitoring and Health 
Disparities – Topics 
 The Biomonitoring Futures Project and 
the Disparity Reducing Advances Project
 Biomonitoring in the context of causes of 
disparities  
 Cancer 2015; Diabetes 2015
 Advances in biomonitoring – diabetes, 
cancer and healthy living/prevention
 Accelerating biomonitoring as a disparity 
reducing advance
5
Biomonitoring Futures Project and 
the “DRA Project”
These findings are from the 
“Biomonitoring Futures Project”, 
funded by the Robert Wood 
Johnson Foundation, a 
component of of IAF’s Disparity 
Reducing Advances Project  
6
IAF’s Disparity Reducing Advances 
Project
The DRA Project is a multi-year, 
multi-stakeholder project developed 
by the Institute for Alternative 
Futures (IAF) to identify and 
accelerate the most promising 
advances for bringing health gains to 
the poor and marginalized.
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DRA Project Sponsors
National Cancer Institute, Center to 
Reduce Cancer Health Disparities
Agency for Healthcare Quality and 
Research
Robert Wood Johnson Foundation
Florida Hospital
University of Texas Medical Branch
8
DRA Project Partners
•Active Living by Design
•Alliance for Health Reform
•American Cancer Society
•American College of Nurse Practitioners
•Center for Information Therapy
•Center for Minority Health at the University of Pittsburgh
•Center for Public Health Practice at Emory University
•Central Florida Family Health Center 
•Clinical Directors Network
•Corporate Office of Science and Technology (COSAT), 
Johnson & Johnson
• Detroit Medical Center 
•Health Resources and Services Administration
•Henry Ford Health System
•Hill Health Center
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DRA Project Partners
•Institute for Alternative Futures
•Institute for Community Health
•Institute for Healthcare Improvement
•Institute for the Elimination of Health Disparities at The 
University of Medicine and Dentistry of New Jersey 
•Intercultural Cancer Council
•Leadership by Design, Inc.
•Maryland Department of  Health and Mental Hygiene
•Medical Automation Research Center at the University 
of Virginia 
•Planetree
•Prevention Institute 
•Resource Center for Health Policy at the University of 
Washington
•Samueli Institute for Information Biology 10
Your Organizations are welcome to 
join the DRA Project 
 The information presented here is 
available at
• www.altfutures.com/dra
• www.altfutures.com/bfp
 If you and your organization are 
interested in becoming a DRA Project 
Partner – contact Clem Bezold or Sandra 
Tinkham at IAF 
(stinkham@altfutures.com).
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Why the DRA Project Is Important
 Health disparities are significant
 They are not perceived by most in the US
 Pursuit of equity (fairness) is a trend, like slavery 
and women’s rights, that will take time and 
support, but can be accelerated
 Equity in:  WHO Health For All, Healthy People 
2010, IOM’s Crossing the Chasm Report
 There will be advances – some of which can be 
identified and accelerated to reduce disparities
 The DRA Project, using us – the DRA Partner 
Network and those we affect – can do this.  
Initial List of Disparity 
Reducing Areas & 
Specific Advances
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Initial Advance Areas to Consider
 Community health and prevention
 Better quality health care – More 
effective, caring treatment  
 Complementary and alternative 
approaches
 Risk Identification
 Biomonitoring/Bioinformatics 
 Behavior coaching/reinforcement 
14
Biomonitoring in the context 
of causes of disparities
 The most important factors needed to reduce 
health disparities include:
• Elimination of poverty
• Meaningful jobs paying a living wage
• Effective education through 12th grade
• Universal access to effective health care
 We recognize these, but they are beyond the 
scope of the DRA Project, which is focusing on 
key advances in health care and public health 
 In key diseases early detection of the disease or 
predisease states, in affordable, culturally 
appropriate, and sustainable ways can be 
significant in reducing disparities.   
15
When Biomonitoring is not 
enough
 There is an important biomonitor
that is inexpensive, easy to use, 
commonly availble.  It provides 
important information on risk 
factors for cancer, diabetes, and a 
variety of other diseases.  It also is 
important for managing diabetes.
 But is often ignored   
16
“The Bathroom Scale 
Problem”
 Where biomonitoring requires 
change it may be ignored.  
 The bathroom scale is low cost, 
easy to use, widely available.  Its 
results are significant for 
preventing or treating many 
diseases. Yet weight and the 
resulting BMI score are often not 
acted on.
 Biomonitoring needs to be 
connected to behavior change as 
relevant.  
17
The Biomonitoring Futures Project
 Biomonitoring is one area of disparity 
reducing advance.  The Robert Wood 
Johnson Foundation has provided 
funding to consider the future 
applications of biomonitoring and its 
role in reducing health disparities. 
 The BFP is a component of the larger 
DRA Project.
18
Biomonitoring Futures Project
 Focus of the project: 
• Cancer (esp. breast, lung & colon)
• Diabetes
• Prevention/Healthy Living
 Findings of BFP Research, including
• Diabetes and Cancer 2015
• Health Information Systems 2015
• Emerging biomonitoring platforms
Papers available at www.altfutures.com/BFP
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Bill Rowley, M.D.
Institute for Alternative Futures
Biomonitoring Futures Project
20
Biomonitoring Platforms
21
Biomonitoring Platforms
22
Biomonitoring Platforms
 Portable – point or care or home
 Easy to use
 ~ Painless
 Fast result
 Reliable
 Data captured
 Inexpensive?
23
How Would One Know?
Concept in 
research 
journal Conference poster 
session or paper
Optimistic media 
release from startup 
company to gain 
funding
Trial published
Update on FDA 
approval process
Company marketing 
material
Disease 
advocate
24
The hurdles
 Develop an idea to solve a problem
 Find the revenue
 Do the science & engineering
 Clinical trials – evidence of effectiveness
 Possibly regulatory approval
 Marketing 
 Acceptance by physicians, payers, patients
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The hurdles
 Does it work – where is the evidence?
 Does it fit into care delivery or daily life?
• Easy to use
• Little discomfort or hassle
• Fast, reliable results
• Makes it easy for action to be taken
• Culturally appropriate
• Low cost
• Compatible with information technology
Value for improving health and reducing disparities
26
Uses
 Predictive medicine – forecast disease
 Prevention
 Screening
 Behavior Modification
 Definitive Diagnosis
 Effective Disease Management
• Empowering patient self-care
• Selecting appropriate therapies
• Confirming therapy is effective
• Identifying relapses or complications
• Help with prognosis
Doing any of these 
things well should 
help improve health 
and reduce disparities
27
Which will be the biomonitoring winner
by 2015?
 Blood spot
 Breath tests
 Imaging tests
 Saliva tests
 Serum
 Skin tests
 Stool tests
 Tissue tests
 Urine tests
 Others
 Chemistry
 Electrical
 Genome
 Light
 Lipids
 Metabalome
 Organisms
 Proteome
 VOCs
 Etc… 28
Consider Diabetes 
A paradigm of the 
problem and the 
opportunities
29
NYC’s Stealth Epidemic
 800,000 New Yorkers have diabetes
 Prevalence 30% higher than U.S.
 New cases occurring twice as fast
 One in three children will get diabetes                
- One in two for Latino and Black women
 North of 96th street 20% have diabetes; South 
the prevalence is 1%
 30% don’t know they have the disease                
- 2/3 who do know aren’t doing enough to treat it
 Half of hospitalized patients are diabetic
N.R. Kleinfield, Diabetes and Its Awful Toll Quietly Emerge as a Crisis, NYT, 1/9/06 and Living at the 
Epicenter of Diabetes, Defiance and Despair, NYT, 1/10/06 30
Diabetes in the U.S. in 2025
 50 million with diabetes
 45 million pre-diabetics
 Annual new cases of serious morbidity:
• 70,000 blind
• 119,000 renal failure on dialysis
• 239,000 lower extremity amputations
 622,000 deaths contributed by diabetes
 $351 billion direct & indirect cost
Rowley & Bezold, Diabetes Forecasts to 2025 and Beyond: The Looming Crisis Demands Change, 2005
If we don’t change…
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Diabetes in the U.S. in 2025
 Diabetes is tied to the epidemic of obesity
 2/3 of Americans are overweight; 1/3 obese
 Lifetime risk white men:
• 92% overweight
• 49% obese
 15% adolescents overweight                             
- 23% of Blacks & Hispanics
 50% of childhood diabetes now type 2 
KM Flegal, Prevalence and Trends in Obesity Among US Adults, 1999-2000, JAMA, 2002                                                RS 
Vasan, Estimated Risks for Developing Obesity in the Framingham Heart Study, Ann Intern Med, 2005                                 CL 
Ogden, Prevalence and Trends in Overweight Among US Children and Adolescents, JAMA, 2002
Why is there an epidemic of diabetes?
women:
• 81% overweight
• 48% obese  
32
Diabetes in the U.S. in 2025
25 yrs14 yrs53%Hispanic
28 yrs20 yrs49%Black
25 yrs16 yrs31%White
FEMALE
24 yrs15 yrs45%Hispanic
24 yrs17 yrs40%Black
22 yrs13 yrs27%White
MALE
Quality 
Adjusted Life 
Years Lost
Life Years 
Lost        
(Onset @ 30) 
Risk of 
Diabetes
KMV Narayan, Lifetime Risk for Diabetes Mellitus in the United States, JAMA, 2003
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Preventing Diabetes?
Prevention
41 Million with Pre-diabetes
 50% will develop diabetes within 10 yrs
 Diabetes can be prevented 58% of time
• Loss 8-15 pounds
• 30 minutes of activity 5 times a week
 Yet usually not screened and little urgency 
in managing prediabetes
34
Treating diabetes in NYC
Ian Urbina, In the Treatment of Diabetes, Success Often Does Not Pay, NYT, 1/11/06
Fee
¾ of New York’s hospital diabetes centers forced to 
close because they failed to make money
(Based on average charges in New York City and Medicare reimbursement rates)
Ophthalmologist
$300
Endocrinologist
$200
Diabetes 
Educator
$70
Nutritionist
$70
Podiatrist
$150-200
Reimburse $100 $225 $15-30 $15-30 $30-90
Cum Loss $100 $175 $215-230 $255-285 $375-395
Chronic Disease Management
35
Treating diabetes in NYC
Ian Urbina, In the Treatment of Diabetes, Success Often Does Not Pay, NYT, 1/11/06
Fee
Outpatient 
Diagnostics
Angiogram
$145
Doctor 
Visit
Sore on foot
$53
Hospitalization
Hospitalization 
(for amputation)
$7,733-17,594
Physical 
Therapy
Rehab
$160
Prosthetic 
Leg
Manufacture 
and fitting
$11,668
Paid $81 $214 $19,093 $117 $12,923
Profit $28 $69 $1,449-11,360 $-43 $1,255
A hospital can get reimbursed $50,000 for 
bariatric surgery or $20 for a nutritionist
System encourages people to get sick and then 
providers t paid for treati g them!
36
Treating diabetes in NYC
9-12 year delay in diagnosis
20% already have eye, nerve or 
kidney damage by time diagnosed
Medicaid pays for one visit a day; 
nurse call for checkup not paid; 
insurance pays for 1 test strip/day
90% of diabetics don’t know their 
HA1c scores
Lack of urgency - takes ~ 6 
months to address abnormal HA1c
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Treating diabetes in NYC
 “Diabetes centers closed because they failed to 
make money”
 “As the epidemic of diabetes has grown, more 
that 100 dialysis centers have opened in the city”
 “ Patients don’t test their blood as often as they 
should because they can’t afford the equipment”
 “Patients wait months to see endocrinologists”
 “Insurers limit diabetes benefits for fear they will 
draw the sickest, most expensive patients”
 “Until we address the financing & reimbursement 
structure, this disease is going to rage out of 
control” Jan Urbina, In the Treatment of Diabetes, Success Often Does Not Pay, NYT, 1/11/06 38
Preventing Diabetes

39
Diabetes Control by Coordinating 
Health Actions
DeathDiabetes with 
Complications
Diabetes 
without 
Complications
Pre-
DiabetesPopulation
Society’s Health 
Response
Primary 
Prevention
Obesity
Secondary 
Prevention
Tertiary 
Prevention
HyperlipidemiaHypertension
Source: J. Essien -- The CDC’s Diabetes Systems Modeling Project: Developing a New Tool 
for Chronic Disease Prevention and Control, 2004 40
Preventing Diabetes 
The diabetes prevention trial of NIH 
showed that 58% of individuals at 
high risk for diabetes could prevent 
conversion to Type 2 diabetes (a life-
long chronic disease with 
complications such as blindness, 
amputations and kidney failure.)
Source: Prescription for a Healthier Michigan, May 2004
41
How will we as a 
society solve the 
diabetes problem 
in the future?
42
The History of Health 2025
 Prevention
 Screening
 Behavior modification
 Effective management of chronic diseases
 Empowered patient self-care
 Advances in biotechnology and information
 Personalized medicine
 Access to care
 Address the obesogenic environment
 Address social determinants of health
Disparities Reducing Advances Project                           
April 6, 2006   Alexandria, Virginia
Institute for Alternative Futures              
100 N. Pitt St, Suite 235, Alexandria, VA 22314        
703-684-5880   www.altfutures.com
8
4/6/2006
43
Type 2 diabetes
Role for BiomonitoringComponent of 
Management
Information and coaching for healthy living 
– diet and exercise
Prevention
Gene patterns, including mitochondrial 
genes Possibly protein or metabolic patterns
Forecast Risk
Identify prediabetes, diabetes,  dyslipidemia 
hypertension
Screening
How well controlling HgA1c, lipids, BP Behavior Modification
Easy testing with rapid results at point of 
care
Disease Management
Biomonitoring to help management -
wireless capture and longitudinal record
Patient self-care
44
Glucose Biomonitoring
45
Glucose Biomonitoring
 Polymerized Crystalline Colloidal Arrays Photonic 
Cosmetic Contact Lenses
 Detection of Glucose and other Biomedical 
Analytes on Biosensor Surfaces using Fractal 
Analysis
 A glucose Biosensor Encapsulated in Erythrocytes
 Carbon Microstructures for Glucose Biosensor
 New Biosensor Technologies: Your Personal, 
Portable and Always On-call Physician
46
Glucose Biomonitoring
I am convinced we will have a 
noninvasive glucose monitor 
before 2015
But I do not know which platform 
technologies will succeed
Bill Rowley, MD,  IAF
Whichever becomes available, we 
must make sure it is leveraged to 
reduce health disparities
47
Biomonitoring & Behavior
Games & Reinforcement
How do we leverage 
biomonitoring to improve 
compliance and change behavior?
48
Bill Rowley, M.D.
Institute for Alternative Futures
Biomonitoring Futures Project      
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Cancer Burden
 Leading cause of death for those < 85
 ½ of men and 1/3 of women will develop 
cancer during lifetime
 1,373,000 new cases of cancer this year
 Death rates now dropping ~ 1% per yr
 Still 570,300 will die of cancer this year
 Lung cancer
• 172,500 new cases expected in 2006
• Biggest killer – 163,500 deaths in 2006
• Incidence declining for men, level for women
50
Cancer Burden
 Breast cancer 
• Most common female cancer – 211,000 
• Second leading cause of death – 40,400
• Incidence ↑ 0.3% per year
• Mortality ↓ 2.4% per year
 Colon cancer
• Third most common – 145,300
• Second most deadly – 56,300
• Incidence and death rates declining
51
Cancer
Role for BiomonitoringComponent of 
Management
Information and coaching for healthy living 
– diet, exercise, not smoking, etc.
Prevention
Gene and protein patterns correlated with 
cancer risk
Forecast Risk
Identify pre-cancer, cancerScreening
Quit smoking Behavior Modification
Identify cancer subtype and 
pharmacogenomics for personalized Rx; 
Monitor effectiveness of Rx & recurrence
Disease Management
Testing with wireless capture and 
longitudinal record; ideal if non-invasive
Patient self-care
52
Screening Compliance
 Mammogram
• 61.5% of women over 40 had one last year
• 43% if didn’t finish high school
• 28.9% if no insurance coverage
American Cancer Society Guidelines for the Early Detection of Cancer, 2006
 Stool Fecal occult blood testing
• 19% over 50 y/o had test last year
• 9.3% if no health insurance (<65 y/o)
 Colonoscopy in past 5 years
• 45.6% of over 50 y/o had test
• 18.8% if no health insurance (<65 y/o)
53
Screening Compliance
 Improve health access
• Having health insurance
• Having usual source of care & regular doctor
• Offering the test during every encounter –
electronic medical record tracking
 Improved patient education
 New biomarkers that are less embarrassing 
or uncomfortable
 Inexpensive screening biomonitoring tests
How can we improve compliance?
54
Protein and Gene Biomarkers
 Gene variations associated with higher risk
• Single genes – BRCA1 & BRCA2
• Genomic fingerprints
• DNA methylation – 50 genes where plays role 
in cancer
• Abnormal genes in established cancers –
presence of epidermal growth factor receptor 
mutations
 Protein markers
• Single protein like PSA, CA 125
• Protein profiling – OvaCheck for ovarian CA
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Protein and Gene Biomarkers
 Could look for proteins or genes in blood, 
stool, urine, saliva
• For cancer often need to test tissue
 Need good clinical trials to determine if 
effective
 At present tests are very expensive $1-3K
 Expect it will be some time before 
inexpensive screening tests are available
Are there any promising candidates for 2015?
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Breath Test for Lung Cancer
• 67 primary lung cancers compared to 41 controls
• Sensitivity 89.6%, specificity 80.5%
Collected breath samples on 178 patients before 
bronchoscopy
Will breath testing be the future screening 
procedure for lung cancer we are looking for?
57
Breath Test for Cancer
 Lung Cancer 
• 55 Bx proven patients & 83 controls
• Sensitivity 99%, specificity 99%  
 Breast Cancer
• 31 Bx proven patients & 83 controls
• Sensitivity 88%, specificity 98%
 Bladder Cancer
• 36 patients & 108 controls
• Sensitivity 41%
 Patterns of biochemical markers
Canine Scent Detection of Cancer
58
Saliva Test for Cancer
 Assess DNA, mRNA, proteins,   
bacteria patterns, etc.
 Current uses:
• Alcohol, illegal drugs
• Hormone levels, pregnancy
 Oral cancer, risk of cavities
 Patterns of mRNA or bacteria 
being evaluated for breast 
cancer
 Convenient for point of care
59
Craig Bettles
Institute for Alternative Futures
Biomonitoring Futures Project  
60
RESULTS
INCREASED RISK:
Condition Relative Risk Lifetime Risk
Alzheimer’s Dis. 3.4                 40%
Heart Disease 2.7 60%
Prospective Medicine
 Genetic & proteomic profile
 Lifestyle & psychosocial profile
 Analysis of exposures
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Genomic Biomarkers
 Identifying Gene Variations that Increase 
Risk
• DeCode Genetics has identified a gene 
carried by 1/3 of Americans that might 
indicate added risk of type 2 diabetes.
 Gene Patterns (Genomic Fingerprints)
• Kidney disease in Type 2 Diabetics
• Proinflammatory genetic profiles 
contributing to cardiovascular disease
• Increased risk for different types of cancer
62
Early Screening Detection
 Early & Pre-diabetes
• Saliva Testing for mRNA patterns
• Saliva Testing for Bacteria Populations
• Breath Testing for Acetone
 Cancer & Pre-cancer
• Saliva Testing for mRNA patterns
• Breath Testing for VOCs
• Fecal DNA for Colon Cancer
• DNA Methylation
• Detecting Intraepithelial Neoplasia (IEN)
63
Prospective Medicine
 Early detection of risk
 Early intervention
• Tailored health action plan
• Individualized Chemoprevention
• Behavior modification
64
Biomonitoring for Healthy Living
 Although many diseases are 
caused by genetic makeup, 
about 40-50% of our 
disease burden is due to 
poor lifestyle choices –
people not taking care of 
themselves.  
 Yet only a fraction of the 
$1.9 trillion U.S. health care 
expenditure is spent on 
helping people better 
manage their own health.
65
0%
20%
40%
60%
80%
Don't
Smoke
Maintain
Healthy
Wt.
Eat 5
F&V/d
Exercise
5X30
Do all 4
Healthy Lifestyles
Reeves, Healthy Lifestyle Characteristics Among Adults in the United States, 2000, Arch Intern Med, 2005
Men 1.5% 
Women 4.2%
Survey of 153,000 Americans
Biomonitoring for Healthy Living
66
Biomonitoring for Healthy Living
Five health-related behaviors 
were identified that are risk 
factors for many high 
disparity diseases:
1.Tobacco use 
2.Poor nutrition
3.Lack of physical activity
4.Unsafe sex
5.Drug and alcohol abuse
HEALTH FOR ALL: California’s Strategic Approach to 
Eliminating Racial and Ethnic Health Disparities (2003)
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Biomonitoring for Healthy Living
Personal biomonitors
can detect: 
 Motion & Body 
Position 
 Galvanic skin 
response
 Body Heat
 Heart Rate
 Breath Rate 
In order to facilitate:
 Weight Control
 Preventing Diabetes
 Monitor Stress
 Monitor Some Mental 
Health Conditions
Create a Feedback Loop 
Where Pay More Attention 
to Their Health
68
Behavior
How can we change behavior?
Education
69
Behavior
How can we change behavior?
Education
Coaching
70
Yourself! Fitness
71
Behavior
How can we change behavior?
Education
Coaching
 Incentives to stick with it
•Simulations
•Rewards
•Frequent monitoring
72
Home Monitoring
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Home Monitoring
Smart Home
Please 
remember  
to take your 
medicine
74
Healthy Living & Prevention
By 2015, Community
health centers can check
up on a patient’s health 
remotely and automated
systems warn both the
health provider and the
patient if their health
deteriorates. 
75
Promising Biomonitoring Advances
Promoting Biomonitoring as Disparity 
Reducing Advances: 
Opportunities and Recommendations 
for the Field
From Biomonitoring Futures Project 
76
Promising Biomonitoring Advances
Key Opportunities for Biomonitoring to 
Reduce Disparities:
1. Support continuous, passive monitoring 
for healthy living & prevention
2. Develop an indwelling closed loop insulin 
pump and biomonitoring system
3. Focus on early detection for cancer 
through early screening using blood as a 
platform
4. Support the use of biomonitoring to 
change behavior, upstream, at the 
community and national level 
77
Developing Biomonitoring to Reduce 
Disparities:  Recommendations
1. HRSA and CMS should enhance partnerships 
for evaluating the intersection of biomonitoring 
platforms, specific disease biomarkers, and 
CHCs
2. Clinical Director’s Network and other 
appropriate groups should help design & 
implement controlled studies of effectiveness 
of biomonitoring systems in CHCs as well as 
diffusing best practices
3. Encourage major federal agencies such as 
DoD, NIH and VA to develop a more coherent 
early stage funding programs based around 
biomonitoring for disparity reduction
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Developing Biomonitoring to Reduce 
Disparities:  Recommendations
4. Work with industry associations, such as 
PhARMA and NEMA on their members’
biomonitoring activity and disparity 
reducing opportunities
5. The FDA should encourage testing and 
evaluation of biomonitoring devices 
among populations with less access and 
resources
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Developing Biomonitoring to Reduce 
Disparities:  Recommendations
6. Enhance the ability of CHCs and others 
to design, deploy and evaluate 
experiments/tests of potential 
biomonitoring advances
7. Provide forecasts or estimates of 
platforms under development or in 
consideration as well as potential 
disruptive innovations
8. Identify specific forums to develop and 
share information on biomonitoring for 
disparity reduction
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Developing Biomonitoring to Reduce 
Disparities:  Recommendations
9. Work with organizations to support the 
development of interoperability standards for 
biomonitoring devices
10. Review and encourage reimbursement 
strategies for effective biomonitoring, 
especially around prevention
11. Support a web based directory for 
biomonitoring technology, drug and device 
companies as well as early stage researchers 
and healthcare provides to network around 
biomonitoring for disparity reduction (e.g. 
Medical Automation.org)
81
The DRA Project 2006
 Pursuing Biomonitoring and other 
promising disparity reducing 
advances
82
Explore Promising Advances
 Committees to consider 7 promising 
advances
1. Community Health/Prevention Approaches  
2. Using Cell Phones to Reduce Disparities
3. Enhanced Consumer Support of Navigation of 
Health Care
4. Continuous, Passive Biomonitoring for Health 
and Prevention
5. Implanted, Closed-Loop Insulin Pump and 
Biomonitoring System
6. Early Detection of Cancer Using Blood Testing  
7. Community and National Biomonitoring to 
Support Upstream Change
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1. Community Health/Prevention 
Approaches
 Reinforcing higher physical activity levels and 
safe, walkable communities
 Creating healthy eating programs in schools, 
vending machines and fast food restaurants. 
 Fostering healthy eating by families – affordable, 
healthy food choices in grocery stores and shops
 Developing culturally appropriate healthy menus
 Implementing health education and literacy 
programs in schools and low income communities
 Building social capital and relevant norms
 Using community workers (e.g. barbers and hair 
dressers) as health coaches, lay health advocates 
and prayer buddies
 Implementing church based screening and 
prevention programs
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2. Using Cell Phones to Reduce 
Health Disparities
 Using the cell phone as a platform to distribute 
and access health information
 Using the cell phone for public outreach 
programs for screening, health promotion or 
disease management
 Providing incentives over the cell phone for 
behavior change linked to biomonitoring
 Providing nutritional information over the cell 
phone to help consumers make food choices 
that are both nutritious and culturally 
appropriate
 Using cell phones as a platform for serious 
games that improve health
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3. Enhanced Consumer Support of 
Navigation of Health Care
 A database of common definitions and terms
 Simple and clear documentation to point 
patients in the right direction
 Identifying and supporting ongoing sources of 
payment for consumer navigation
 Best practices on how to harness and enhance 
informal approaches to consumer navigation
 An electronic “Health Compass” for individuals 
for navigating health services
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Other Promising Advances
4. Continuous, Passive Biomonitoring for 
Health and Prevention
5. Implanted, Closed-Loop Insulin Pump 
and Biomonitoring System
6. Early Detection of Cancer Using Blood 
Testing  
7. Community and National Biomonitoring
to Support Upstream Change
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Criteria Committee
The DRA Project has developed a 
set of criteria for identifying the 
most important advances.  These 
criteria will be explored and applied 
to the promising advances and the 
the other specific advances in the 
areas listed above. 
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Draft Criteria for the “most 
important” DRA’s
 Can make a very large, measurable difference in reducing 
health disparities
• Across multiple diseases/conditions or within a single disease
 Stimulates prevention by identifying pre-disease conditions or risks
 Enables earlier detection of the disease
 Enables better, higher cost/benefit ratio treatment
 Lowers morbidity and morbidity  
• Cost-effective enough to be applied and reapplied as necessary
 For the health care provider
 For the consumer/patient
 For the insurer/third party payers
 For society
 Appropriate for multiple poor and marginalized populations
• Culturally, linguistically, age and gender appropriate
• Large scale applicability across populations
 Encourages participation of individuals and key stakeholders
 Can be communicated to decision-makers and the public
 Can be realistically achieved within the next 10 years 
 Can be effectively promoted or accelerated through the DRA 
Project Network 
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DRA in 2006
 Summer of 2006
• Continue Scanning Activities
• Conduct committees on 7 promising 
advances and applying the criteria 
 Fall of 2006
• Second Partners Meeting on Sept. 13th
• Select and Report on Advances and 
Opportunities 
• Develop Forecasts for Advance Areas
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DRA in 2007 & 2008
 Continue to Build the Partner Network
 Pursue and Develop Specific Projects Around 
Promising Advances & Opportunities
 Identify Design Changes in Advances Needed 
to Make Them Relevant to Underserved 
Communities
 Increase Deployment of Selected Advances 
Through the Partner Network
 Increase Deployment of Selected Advances By 
Targeting Decision Makers in Healthcare, 
Industry and Government
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Joining the DRA Project 
 The information presented here is 
available at
• www.altfutures.com/dra
• www.altfutures.com/bfp
 If you and your organization are 
interested in becoming a DRA Project 
Partner – contact Clem Bezold or Sandra 
Tinkham at IAF 
(stinkham@altfutures.com).
